|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 369.19 USD | +1.52% |
|
-3.94% | +12.80% |
| 02-12 | Amgen Inc. Presents at Piper Sandler Virtual Novel Targets in Immunology Symposium, Feb-12-2026 05:00 PM | |
| 02-12 | European Commission approves Amgen's Uplizna® for generalized myasthenia gravis | RE |
40513055bacf63bd.rzlbY482q4_gWxrwF-NZOVpWw309UbItW4OdMld-enI.1QliF_tM8ujRP3GBZZEcdjcFrgkNYsp-aNfaaz4cPTbOAR4v60fKwZM5Ww~6b3bb2f7d3a78aaa7df9e84f8aeaf002
- Stock Market
- Equities
- AMGN Stock
- Charts Amgen Inc.
- News Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition